Linuo Pharmaceutical Packaging advances Brazil plant as H1 revenue rises 34.93%

China's Linuo Pharmaceutical Packaging said its Brazil production facility is expected to begin operations within 2026 and that it has signed a construction agreement for a new site in Egypt, moves aimed at easing overseas capacity constraints. The glass packaging maker also reported H1 2026 revenue of CNY 673m (USD 100m), up 34.93% year on year, while net profit attributable to the parent fell 23.95% to CNY 31m (USD 4.6m) on e-commerce brand investment and share-based payment charges. Overseas revenue more than doubled to CNY 215m (USD 32m).

Why this mattersNew Brazil and Egypt capacity signals a Chinese pharma-glass exporter building local supply as overseas demand outpaces margins.

• Brazil production facility expected to begin operations within 2026
• Construction agreement signed for a new site in Egypt
• H1 2026 revenue CNY 673m (USD 100m), up 34.93% year on year
• Overseas revenue CNY 215m (USD 32m), up 115.02% year on year
• Net profit attributable to parent CNY 31m (USD 4.6m), down 23.95% year on year
• Heat-resistant glass segment revenue CNY 436m (USD 65m), up 53.36%

Relevant to you? Yes No